Ghaleb Hassan Daouk, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urogenital Abnormalities | 4 | 2021 | 255 | 0.530 |
Why?
|
| Nephrotic Syndrome | 3 | 2019 | 380 | 0.340 |
Why?
|
| Urinary Tract | 3 | 2021 | 305 | 0.320 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2021 | 433 | 0.250 |
Why?
|
| Pedigree | 7 | 2020 | 4535 | 0.200 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 567 | 0.150 |
Why?
|
| Mutation | 7 | 2020 | 30192 | 0.140 |
Why?
|
| Nephrocalcinosis | 1 | 2017 | 51 | 0.140 |
Why?
|
| Laminin | 1 | 2019 | 404 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2018 | 2744 | 0.130 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
| Nephrolithiasis | 1 | 2017 | 117 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2020 | 18074 | 0.130 |
Why?
|
| Hypertension | 3 | 2018 | 8616 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 2307 | 0.120 |
Why?
|
| DNA Mutational Analysis | 3 | 2019 | 4111 | 0.120 |
Why?
|
| Genetic Markers | 2 | 2017 | 2603 | 0.120 |
Why?
|
| Podocytes | 1 | 2018 | 389 | 0.110 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 303 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1623 | 0.100 |
Why?
|
| Creatine Kinase | 3 | 1991 | 682 | 0.100 |
Why?
|
| Serine Endopeptidases | 1 | 1995 | 1024 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2969 | 0.080 |
Why?
|
| Endocrine System Diseases | 1 | 2010 | 244 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2018 | 2100 | 0.070 |
Why?
|
| Heredity | 2 | 2017 | 149 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3816 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 551 | 0.070 |
Why?
|
| Child, Preschool | 9 | 2020 | 42510 | 0.070 |
Why?
|
| Autoantibodies | 1 | 1995 | 2114 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 4213 | 0.060 |
Why?
|
| Renin-Angiotensin System | 1 | 2010 | 736 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 2022 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2020 | 6612 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 9600 | 0.060 |
Why?
|
| Angiomyolipoma | 1 | 2006 | 189 | 0.060 |
Why?
|
| Child | 10 | 2020 | 80568 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4277 | 0.050 |
Why?
|
| Leuconostoc | 2 | 1979 | 3 | 0.050 |
Why?
|
| Phenotype | 5 | 2019 | 16714 | 0.050 |
Why?
|
| Kidney | 3 | 2021 | 7073 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1161 | 0.050 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 1979 | 209 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12129 | 0.040 |
Why?
|
| Prognosis | 5 | 2019 | 29890 | 0.040 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
| Syndrome | 2 | 2018 | 3271 | 0.040 |
Why?
|
| Lupus Nephritis | 1 | 2004 | 323 | 0.040 |
Why?
|
| Age of Onset | 2 | 2017 | 3343 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11895 | 0.040 |
Why?
|
| Infant | 5 | 2020 | 36426 | 0.040 |
Why?
|
| Acute Kidney Injury | 2 | 2004 | 1943 | 0.040 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1979 | 96 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 511 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 709 | 0.040 |
Why?
|
| Tuberous Sclerosis | 1 | 2006 | 1039 | 0.040 |
Why?
|
| Adolescent | 7 | 2020 | 88811 | 0.040 |
Why?
|
| Fetofetal Transfusion | 1 | 1999 | 119 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14450 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2018 | 626 | 0.030 |
Why?
|
| Myeloblastin | 1 | 1995 | 101 | 0.030 |
Why?
|
| Humans | 20 | 2021 | 765926 | 0.030 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 168 | 0.030 |
Why?
|
| Kinetics | 4 | 1995 | 6273 | 0.030 |
Why?
|
| Esters | 1 | 1995 | 213 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1774 | 0.030 |
Why?
|
| Mice | 5 | 2020 | 81782 | 0.030 |
Why?
|
| Elastin | 1 | 1995 | 298 | 0.030 |
Why?
|
| Male | 13 | 2020 | 363815 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 2796 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2269 | 0.030 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1995 | 297 | 0.030 |
Why?
|
| Base Sequence | 2 | 2018 | 12405 | 0.030 |
Why?
|
| Young Adult | 4 | 2020 | 59857 | 0.020 |
Why?
|
| Female | 11 | 2020 | 396141 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15401 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6891 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1850 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3208 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 4278 | 0.020 |
Why?
|
| Animals | 5 | 2020 | 168735 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1990 | 527 | 0.020 |
Why?
|
| NADP | 2 | 1979 | 228 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1990 | 341 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1991 | 647 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2018 | 18962 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 1990 | 257 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9296 | 0.020 |
Why?
|
| Proteome | 1 | 2018 | 1896 | 0.020 |
Why?
|
| Graft Survival | 1 | 2019 | 3904 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 548 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 13082 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2019 | 24275 | 0.020 |
Why?
|
| Zebrafish | 1 | 2018 | 3035 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1991 | 1525 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10086 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9334 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1991 | 2342 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3594 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2019 | 4503 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 41680 | 0.020 |
Why?
|
| NAD | 2 | 1979 | 618 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3661 | 0.010 |
Why?
|
| Brain | 2 | 1991 | 27179 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2017 | 5987 | 0.010 |
Why?
|
| Homeostasis | 1 | 1995 | 3338 | 0.010 |
Why?
|
| Transfection | 2 | 1990 | 5738 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2019 | 26380 | 0.010 |
Why?
|
| Nephritis | 1 | 2004 | 146 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14643 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 13026 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22228 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2004 | 434 | 0.010 |
Why?
|
| Urinalysis | 1 | 2004 | 369 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15878 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13614 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 223088 | 0.010 |
Why?
|
| Edema | 1 | 2004 | 759 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21513 | 0.010 |
Why?
|
| Exanthema | 1 | 2004 | 503 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1988 | 6209 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1999 | 470 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1988 | 13398 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1991 | 1384 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1988 | 17596 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20690 | 0.010 |
Why?
|
| Creatinine | 1 | 1999 | 1916 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65194 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 2157 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1990 | 58 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1991 | 285 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 74850 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1991 | 765 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 81537 | 0.010 |
Why?
|
| United States | 1 | 2018 | 72909 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1990 | 456 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 848 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12973 | 0.000 |
Why?
|
| Multigene Family | 1 | 1991 | 1081 | 0.000 |
Why?
|
| Middle Aged | 1 | 2020 | 223016 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1990 | 1688 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1990 | 3070 | 0.000 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 1979 | 7 | 0.000 |
Why?
|
| Acetyl Coenzyme A | 1 | 1979 | 74 | 0.000 |
Why?
|
| Coenzymes | 1 | 1979 | 101 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1990 | 2894 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1979 | 655 | 0.000 |
Why?
|
| Cell Line | 1 | 1991 | 15540 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 30230 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1979 | 2001 | 0.000 |
Why?
|